Outlook Therapeutics
OTLK
OTLK
49 hedge funds and large institutions have $30.3M invested in Outlook Therapeutics in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+19
Holders Change %
+63.33%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
12
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$9.37M |
| 2 |
2
BlackRock
New York
|
$3.92M |
| 3 |
3
Two Sigma Investments
New York
|
$2.8M |
| 4 |
4
Renaissance Technologies
New York
|
$1.87M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$1.67M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$30K | -1,169 | Closed |
|